HT Vista, the innovative technology startup that launched in March, is proud to announce a successful first month of launching its non-invasive, rapid and accurate skin cancer screening device for dogs in the UK. HT Vista is excited to be attending BVA Live in May to continue to showcase the device and provide demos to delegates on stand B61.
The HT Vista device has been well-received by veterinary professionals, with the company’s stand at the British Small Animal Veterinary Association (BSAVA) event last month being inundated with visitors. Many veterinary practices across the UK have already signed up to use the device, and the company is confident that it will continue to attract interest from more clinics and pet owners.
“We are thrilled with the success we’ve had in our first month of business,” said Liron Levy-Hirsch, Managing Director. “I’m very excited that we can now use this technology in the UK. Our team has put in a tremendous amount of work to create a product that provides non-invasive, accurate, and rapid skin cancer screening for dogs, and we’re pleased that it has been so well-received. We’re proud that the device will help increase the number of dogs who are screened as pet owners become familiar with the tool and its place in the screening process. We’re looking forward to showcasing our device at BVA Live and continuing to expand our customer base.”
Alongside launching the device and signing up several practices in both the independent and corporate sectors, HT Vista has continued to build their team of skilled and experienced professionals. The company has welcomed a new account manager and new customer success manager who will help to drive continued growth and success.
HT Vista will be presenting its revolutionary device at the upcoming BVA Live event on stand B61 and look forward to connecting with veterinary professionals who are passionate about animal health and wellbeing. In addition, Liron will be presenting two lectures on the subject “DIY tips for diagnosing cancer of canine subcutaneous and dermal masses in general practice.”
The HT Vista device is a point of care device to determine if a skin mass is benign or not. It uses Heat Diffusion Imaging technology alongside an artificial intelligence-based algorithm, computer vision and signal analysis. It detects the different heat transfer rates of benign and suspicious tissue to accurately determine if a dermal or sub-dermal mass is benign or requires further investigation.
For more information on HT Vista and to book a demo, visit www.ht-vet.com/vistademo